Eotaxin expression in Sephadex-induced lung injury in rats.

[1]  A. Bellini,et al.  Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation , 1998, Clinical and experimental immunology.

[2]  Kazuhiko Yamamoto,et al.  Intracellular localization and release of eotaxin from normal eosinophils , 1998, FEBS letters.

[3]  P. Hellewell,et al.  A CD18/ICAM-1-dependent pathway mediates eosinophil adhesion to human bronchial epithelial cells. , 1998, American journal of respiratory cell and molecular biology.

[4]  C. Martínez-A,et al.  The Coordinated Action of CC Chemokines in the Lung Orchestrates Allergic Inflammation and Airway Hyperresponsiveness , 1998, The Journal of experimental medicine.

[5]  A. Kapp,et al.  Eotaxin‐2 activates chemotaxis‐related events and release of reactive oxygen species via pertussis toxin‐sensitive G proteins in human eosinophils , 1998, European journal of immunology.

[6]  D. Friend,et al.  Eotaxin is required for the baseline level of tissue eosinophils. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Mackay,et al.  Human Eotaxin Induces α4 and β2 Integrin-Dependent Eosinophil Accumulation in Rat Skin In Vivo: Delayed Generation of Eotaxin in Response to IL-4 , 1998, The Journal of Immunology.

[8]  S. Rankin,et al.  Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. , 1998, Blood.

[9]  S. Kimura,et al.  The effects of eotaxin on the surface adhesion molecules of endothelial cells and on eosinophil adhesion to microvascular endothelial cells. , 1997, Biochemical and biophysical research communications.

[10]  C. Mackay,et al.  Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co‐localization of eotaxin mRNA to bronchial epithelial and endothelial cells , 1997, European journal of immunology.

[11]  Q. Hamid,et al.  Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. , 1997, Journal of immunology.

[12]  F. Ishida,et al.  Eosinophilia associated with clonal T-cell proliferation. , 1997, Leukemia & lymphoma.

[13]  M. Stacey,et al.  Eotaxin expression and eosinophilic inflammation in asthma. , 1997, Biochemical and biophysical research communications.

[14]  P. Foster,et al.  Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. , 1997, The Journal of clinical investigation.

[15]  P. Leder,et al.  Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia , 1997, The Journal of experimental medicine.

[16]  M. Cybulsky,et al.  Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. , 1996, The Journal of clinical investigation.

[17]  J. Norgauer,et al.  Recombinant human eotaxin induces oxygen radical production, Ca(2+)-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein. , 1996, Blood.

[18]  P. Hellewell,et al.  Eotaxin stimulates eosinophil adhesion to human lung microvascular endothelial cells. , 1996, Biochemical and biophysical research communications.

[19]  H. Kita,et al.  Chemokines active on eosinophils: potential roles in allergic inflammation , 1996, The Journal of experimental medicine.

[20]  W. Sewell,et al.  Dissociation of production of interleukin‐4 and interleukin‐5 , 1996, Immunology and cell biology.

[21]  P. Leder,et al.  Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia , 1996, Nature Medicine.

[22]  W Newman,et al.  Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. , 1996, The Journal of clinical investigation.

[23]  T. Williams,et al.  Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo , 1995, The Journal of experimental medicine.

[24]  P. Leder,et al.  Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  P. Leder,et al.  Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung , 1995, The Journal of experimental medicine.

[26]  I. Adcock,et al.  Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs. , 1994, Biochemical and biophysical research communications.

[27]  M. Ebisawa,et al.  Eosinophil transendothelial migration induced by cytokines. II. Potentiation of eosinophil transendothelial migration by eosinophil-active cytokines. , 1994, Journal of immunology.

[28]  J. Hsuan,et al.  Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation , 1994, The Journal of experimental medicine.

[29]  T. Williams,et al.  The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. , 1993, Biochemical and biophysical research communications.

[30]  J. Hevel,et al.  Tissue injury caused by deposition of immune complexes is L-arginine dependent. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Durham,et al.  Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. , 1990, The American review of respiratory disease.

[32]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[33]  M. Teixeira.  Eosinophil-active chemokines: assessment of in vivo activity. , 1998, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[34]  M. Ohtsuka,et al.  Cloning of rat eotaxin: ozone inhalation increases mRNA and protein expression in lungs of Brown Norway rats. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[35]  T. Wynn.  The debate over the effector function of eosinophils in helminth infection: new evidence from studies on the regulation of vaccine immunity by IL-12. , 1997, Memorias do Instituto Oswaldo Cruz.

[36]  S. Rankin,et al.  The role of the eosinophil-selective chemokine, eotaxin, in allergic and non-allergic airways inflammation. , 1997, Memorias do Instituto Oswaldo Cruz.

[37]  N. Copeland,et al.  Mouse Eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. , 1996, Immunity.

[38]  A. Herman,et al.  Sephadex induced granulomatous reaction in rats. , 1995, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[39]  U. Deschl,et al.  Intratracheal application of Sephadex in rats leads to massive pulmonary eosinophilia without bronchial hyperreactivity to acetylcholine. , 1992, International archives of allergy and immunology.

[40]  A. Wardlaw,et al.  Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. , 1988, The American review of respiratory disease.

[41]  D. Loegering,et al.  Immunobiology of eosinophils. , 1984, Annual review of immunology.